Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Nanoplastics (NP) and microplastics (MP) accumulate in our environment as a consequence of the massive consumption of plastics. Huge knowledge-gaps exist regarding uptake and fate of plastic particles in micro- and nano-dimensions in humans as well as on their impact on human health. This study investigated the transport and effects of 50 nm and 0.5 μm COOH-modified polystyrene (PS) particles, as representatives for NP and MP, in different biological models in vitro. Acute toxicity and potential translocation of the particles were studied at the human intestinal and placental barrier using advanced in vitro co-culture models. Furthermore, embryotoxicity and genotoxicity were investigated as highly sensitive endpoints. Polystyrene was not acutely toxic in both sizes (nano- and microparticles). No transport across the intestinal and placental barrier but a cellular uptake and intracellular accumulation of PS nano- and microparticles were determined. The particles were identified as weak embryotoxic and non-genotoxic. In contrast to single-organ studies, this multi-endpoint study is providing a data-set with the exact same type of particles to compare organ-specific outcomes. Our study clearly shows the need to investigate other types of plastics as well as towards long-term or chronic effects of plastic particles in different biological models in vitro.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.tiv.2019.104610DOI Listing

Publication Analysis

Top Keywords

nano- microparticles
12
biological models
12
models vitro
12
plastic particles
8
intestinal placental
8
placental barrier
8
particles
6
multi-endpoint toxicological
4
toxicological assessment
4
assessment polystyrene
4

Similar Publications

Lead is an extremely hazardous pollutant that poses a severe threat to the ecosystem. It enters the atmosphere in the form of nano- and microparticles and is then carried by wind and water. These particles easily dissolve in water, turning into ions which are easily absorbed by living organisms.

View Article and Find Full Text PDF

Heparin-loaded silk fibroin microparticles/bacterial nanocellulose (Hep@SFMPs/BNC) conduits for application as small-caliber artificial blood vessels.

Carbohydr Polym

November 2025

State Key Laboratory of Advanced Fiber Materials (Donghua University), Shanghai 201620, China; College of Biological Science and Medical Engineering, Donghua University, No. 2999 North Renmin Road, Shanghai 201620, China; Shanghai Engineering Research Center of Nano-Biomaterials and Regenerative Med

Small-caliber artificial blood vessels are highly demanded and face challenges, including thrombosis and intimal hyperplasia. The excellent properties of bacterial nanocellulose (BNC) make it an excellent material for preparing artificial blood vessels. Heparin (Hep)-loaded silk fibroin microparticles (SFMPs) were synthesized in situ within the conduit wall via liquid pressure injection and phase separation, aiming to improve BNC's anticoagulant properties.

View Article and Find Full Text PDF

Pulmonary fibrosis is a life-threatening disorder characterized by excessive extracellular matrix (ECM) deposition and progressive dysfunction. The disease progression is closely associated with increased ECM stiffness, which compromises normal tissue mechanics and leads to respiratory failure. Although its etiology is multifactorial, immune-mediated responses are central drivers of fibrotic remodeling through inflammatory cytokine release and aberrant tissue repair.

View Article and Find Full Text PDF

Oral mucositis (OM) is a severe inflammatory condition of the oral mucosa that is commonly associated with cancer therapies. Traditional treatments typically have limited efficacy and significant side effects, necessitating alternative approaches. Nanobased drug delivery systems (DDSs) present promising solutions, enhancing therapeutic outcomes while minimizing side effects.

View Article and Find Full Text PDF

A majority of the global population suffers from eye diseases, but few effective treatment options are available with ophthalmic drug therapies. The reasons that have been identified are (1) lack of awareness about the options for treatments, drugs, polymeric science, or physiological barriers, (2) limitations in bringing drug therapies to the posterior segment of the eye due to physiological or anatomical limitations, and (3) regulatory and production difficulties of ocular drug products. Innovative ocular medication delivery and therapies are covered in this study, including hydrogels, nano micelles, implants, nanoparticles, microparticles, liposomes, in situ gels, and microneedles.

View Article and Find Full Text PDF